Evidence map›Paper›PMID 42292198›Full record

ArticleFrontiers in medicine2026

Smoking and mortality risk in COPD patients: a prospective cohort study in Sichuan, China.

Boke Chen, Di Wu, Xiaofang Chen, Xia Wu, Mingqiang Yuan, Yujin He, Zhuo Wang, Xueli Zhang, Jun Lv, Canqing Yu and 4 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Boke Chen *Department of Epidemiology and Biostatistics, School of Public Health, Chengdu Medical College, Chengdu, China.
Di Wu *Department of Epidemiology and Biostatistics, School of Public Health, Chengdu Medical College, Chengdu, China.
Xiaofang ChenPengzhou Disease Control and Prevention Center, Pengzhou, Sichuan, China.
Xia WuPengzhou Disease Control and Prevention Center, Pengzhou, Sichuan, China.
Mingqiang YuanPengzhou Disease Control and Prevention Center, Pengzhou, Sichuan, China.
Yujin HeSichuan Center for Disease Control and Prevention, Chengdu, China.
Zhuo WangSichuan Center for Disease Control and Prevention, Chengdu, China.
Xueli ZhangSichuan Health Information Center, Chengdu, China.
Jun LvDepartment of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China.
Canqing YuDepartment of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China.
Pei PeiPeking University Center for Public Health and Epidemic Preparedness and Response, Beijing, China.
Dianjianyi SunDepartment of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China.
Xianping WuSichuan Provincial Health and Health Commission, Chengdu, China.
Xiaofang ChenDepartment of Epidemiology and Biostatistics, School of Public Health, Chengdu Medical College, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To assess the association between smoking and mortality in patients with chronic obstructive pulmonary disease (COPD) in Sichuan Province, China. Methods: Data concerning COPD patients in Pengzhou, Sichuan was collated from the China Kadoorie Biobank (CKB). COPD was defined as post-bronchodilator forced expiratory volume in 1 s/forced vital capacity of <70%. The relationship between smoking and mortality was evaluated by Cox proportional hazards regression. Results: Eight thousand five hundred one COPD patients, aged 30-79 years, were enrolled enabling analysis of 85,600 person-years of follow-up data (mean follow-up: 10.07 years). Two thousand deaths occurred during the period of investigation, including 665 from COPD and 1,116 from cardiovascular disease (CVD). Ex-smokers were at higher risk of both all-cause mortality [hazard ratio (HR) 1.56; 95% confidence interval (CI) 1.36-1.80], COPD (HR 2.24; 95% CI 1.80-2.80) and CVD mortality (HR 1.54; 95% CI 1.28-1.85) than those who had never smoked. An increased duration of smoking was associated with higher risk of death. A dose-response relationship was observed. Patients who smoked > 20 g tobacco/day had 35% higher all cause, 66% higher COPD and 34% higher CVD mortality risk. Those with cumulative exposures ≥ 250,000 g had the highest risks of all outcomes. Earlier age of smoking onset and oral only smoke intake (as opposed to lung inhalation) were also linked to greater mortality risk. Conclusion: Smoking was an independent risk factor for COPD-specific, CVD and all-cause mortality in COPD patients from Sichuan with higher tobacco consumption giving a stronger association.

Indexed as

COPDCVDmortality riskprospective studysmoking

Identifiers

PMID42292198
PMCPMC13260164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.